The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
What does it do?
Cigna is one of America's largest health insurance and pharmacy benefit companies. When your employer offers health insurance, there's a good chance Cigna is the one actually paying your doctor bills and managing your prescriptions. They also run Evernorth, a massive behind-the-scenes operation that handles prescription drug benefits for other insurers and employers — basically acting as the middleman between drug companies, pharmacies, and patients. Think of them as both the health insurance company on your card and the invisible engine processing millions of pharmacy transactions every day.
Healthcare is one of the few industries that grows almost regardless of the economy — people don't stop getting sick in a recession. Cigna's pharmacy services arm, Evernorth, is rapidly becoming the company's biggest growth engine at a time when drug costs and specialty medications are exploding in importance. With GLP-1 weight-loss drugs like Ozempic reshaping how America manages chronic disease, whoever controls the pharmacy benefit supply chain sits in a very powerful position.
How does it make money?
Cigna pulls in roughly $275 billion in revenue, making it one of the largest companies in the US by sales. The bulk of that comes from Evernorth Health Services, which processes prescription drug claims and manages pharmacy benefits for employers and health plans — essentially collecting a fee on every prescription transaction that flows through its network. The Cigna Healthcare segment collects premiums from employers and individuals in exchange for health coverage, then profits when medical costs come in below what was collected. Net income was $6 billion last year on that enormous revenue base, reflecting the razor-thin but high-volume margins typical of this industry.
Why do investors care?
Cigna grew revenue from $247 billion to $275 billion in a single year — an 11% jump — mostly driven by Evernorth's expanding pharmacy services business. The growth story is about becoming the indispensable plumbing of the US healthcare system: the more prescriptions, specialty drugs, and complex care coordination that exists, the more Evernorth gets paid to manage it. For the thesis to work, Cigna needs to keep winning large pharmacy benefit management contracts, avoid major disruptions from drug pricing legislation, and successfully navigate rising medical costs in its insurance arm. The stock trades at a relatively modest valuation compared to its earnings, which attracts investors who believe the market is underpricing its scale.
Deep Dive
MemberA full investor briefing on The Cigna Group — history, leadership, risks, and outlook.